CORC  > 中国医学科学院 北京协和医学院
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy
Wang Xin; Tian Yuan; Tang Yuan; Hu Zhi-Hui; Zhang Jia-Jia; Fu Gui-Shan; Ma Pan; Ren Hua; Zhang Tao; Li Ning
2017
卷号8期号:24页码:39727-39735
关键词gastroesophageal junction cancer gastric cancer helical tomotherapy intensity-modulated radiotherapy volumetric-modulated arc therapy
ISSN号1949-2553
DOI10.18632/oncotarget.14459
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6367450
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Wang Xin,Tian Yuan,Tang Yuan,et al. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy[J],2017,8(24):39727-39735.
APA Wang Xin.,Tian Yuan.,Tang Yuan.,Hu Zhi-Hui.,Zhang Jia-Jia.,...&Jin Jing.(2017).Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.,8(24),39727-39735.
MLA Wang Xin,et al."Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy".8.24(2017):39727-39735.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace